As of 2025-09-17, the Relative Valuation of 89Bio Inc (ETNB) is (26.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.97 USD, the upside of 89Bio Inc based on Relative Valuation is -428.5%.
The range of the Relative Valuation is (20.64) - (34.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 6.8x - 11.9x | 9.4x |
| Fair Price | (20.64) - (34.54) | (26.18) |
| Upside | -359.0% - -533.4% | -428.5% |
| Date | P/E |
| 2025-09-08 | -2.80 |
| 2025-09-05 | -2.92 |
| 2025-09-04 | -2.84 |
| 2025-09-03 | -3.04 |
| 2025-09-02 | -3.03 |
| 2025-08-29 | -2.97 |
| 2025-08-28 | -3.10 |
| 2025-08-27 | -3.08 |
| 2025-08-26 | -3.08 |
| 2025-08-25 | -3.00 |
| 2025-08-22 | -3.11 |
| 2025-08-21 | -3.03 |
| 2025-08-20 | -3.00 |
| 2025-08-19 | -2.96 |
| 2025-08-18 | -3.11 |
| 2025-08-15 | -3.04 |
| 2025-08-14 | -3.00 |
| 2025-08-13 | -3.01 |
| 2025-08-12 | -2.98 |
| 2025-08-11 | -2.89 |
| 2025-08-08 | -3.02 |
| 2025-08-07 | -2.97 |
| 2025-08-06 | -3.12 |
| 2025-08-05 | -3.19 |
| 2025-08-04 | -3.08 |
| 2025-08-01 | -3.02 |
| 2025-07-31 | -3.13 |
| 2025-07-30 | -3.14 |
| 2025-07-29 | -3.04 |
| 2025-07-28 | -3.14 |
| 2025-07-25 | -3.16 |
| 2025-07-24 | -3.29 |
| 2025-07-23 | -3.32 |
| 2025-07-22 | -3.29 |
| 2025-07-21 | -3.33 |
| 2025-07-18 | -3.46 |
| 2025-07-17 | -3.51 |
| 2025-07-16 | -3.50 |
| 2025-07-15 | -3.46 |
| 2025-07-14 | -3.66 |
| 2025-07-11 | -3.62 |
| 2025-07-10 | -3.55 |
| 2025-07-09 | -3.48 |
| 2025-07-08 | -3.28 |
| 2025-07-07 | -3.37 |
| 2025-07-03 | -3.35 |
| 2025-07-02 | -3.33 |
| 2025-07-01 | -3.21 |
| 2025-06-30 | -3.23 |
| 2025-06-27 | -3.25 |